Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cibus (CBUS) Shares Outstanding (Weighted Average) (2016 - 2025)

Cibus' Shares Outstanding (Weighted Average) history spans 9 years, with the latest figure at $23.6 million for Q3 2024.

  • For Q3 2024, Shares Outstanding (Weighted Average) rose 195.61% year-over-year to $23.6 million; the TTM value through Sep 2024 reached $23.6 million, up 195.61%, while the annual FY2023 figure was $10.3 million, 1021.2% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2024 was $23.6 million at Cibus, up from $21.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $37.5 million in Q4 2021 and bottomed at $919959.0 in Q4 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $21.4 million (2024), against an average of $19.9 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) tumbled 97.55% in 2022 before it soared 2011.32% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $33.9 million in 2020, then grew by 10.61% to $37.5 million in 2021, then crashed by 97.55% to $919959.0 in 2022, then skyrocketed by 1021.2% to $10.3 million in 2023, then skyrocketed by 128.67% to $23.6 million in 2024.
  • Per Business Quant, the three most recent readings for CBUS's Shares Outstanding (Weighted Average) are $23.6 million (Q3 2024), $21.4 million (Q2 2024), and $20.9 million (Q1 2024).